PS Ratio: 354.11

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 354.11 is 355% above its estimated 5-year average of 77.85, near the high end of its estimated 5-year range (1.35–494.28).

As of 2026-10-06T18:22:15.025Z. 151.36% above its estimated 12-month average of 140.88.

NAMS PS Ratio Metrics

P/S vs. estimated history

At 354.11, P/S is above its estimated 5-year median — higher than 96% of readings in its estimated 5-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for NewAmsterdam Pharma Company N.V. (NAMS)?

The P/S ratio for NAMS stock is 354.11.

Is NewAmsterdam Pharma Company N.V.'s P/S ratio high or low?

The P/S ratio of 354.11 is 355% above its estimated 5-year average of 77.85, near the high end of its estimated 5-year range (1.35–494.28).

What is the estimated TTM average P/S ratio for NewAmsterdam Pharma Company N.V. (NAMS)?

The estimated TTM average P/S ratio for NAMS stock is 140.88.

What is the estimated 3Y average P/S ratio for NewAmsterdam Pharma Company N.V. (NAMS)?

The estimated 3Y average P/S ratio for NAMS stock is 117.54.

What is the estimated 5Y average P/S ratio for NewAmsterdam Pharma Company N.V. (NAMS)?

The estimated 5Y average P/S ratio for NAMS stock is 77.85.

Showing the most recent 260 of 1,131 data points. The chart above shows the full history.

Related Metrics